A Phase 2 Open Label Extension Study in Participants With Nonsense Mutation Aniridia
NCT04117880
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Study cancelled before protocol was implemented.
Conditions
Aniridia
Interventions
DRUG:
Ataluren
Sponsor
PTC Therapeutics